MicroRNA-497 Suppresses Proliferation and Induces Apoptosis in Prostate Cancer Cells

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3499-3502

  Wang, Li ^a   Li, Bo ^a   Li, Lei ^a   Wang, Te ^b  

^a HEBEI UNIVERSITY OF ENGINEERING   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Growth reduction; MiR 497; Prostate cancer

Indexed keywords

EID: 84882637292     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3499     Document Type: Article

References (24)

1. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
2. Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66.
3. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?.Nat Rev Genet, 9, 102-14.
4. Guo ST, Jiang CC, Wang GP, et al (2013). MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene, 32, 1910-20.
5. Hagman Z, Larne O, Edsjo A, et al (2010). miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Int J Cancer, 127, 2768-76.
6. He L, Hannon GJ (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 5, 522-31.
7. Hsieh IS, Chang KC, Tsai YT, et al (2013). MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by down-regulating the Wnt/beta-catenin signaling pathway. Carcinogenesis, 34, 530-8.
8. Kefas B, Godlewski J, Comeau L, et al (2008). microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res, 68, 3566-72.
9. Li D, Zhao Y, Liu C, et al (2011). Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res, 17, 1722-30.
10. Linsley PS, Schelter J, Burchard J, et al (2007). Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol, 27, 2240-52.
11. Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.
12. Luo M, Shen D, Zhou X, Chen X, Wang W (2013). MicroRNA-497 is potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery, 12, 751-9.
13. Porkka KP, Pfeiffer MJ, Waltering KK, et al (2007). MicroRNA expression profiling in prostate cancer. Cancer Res, 67, 6130-5..
14. Ribas J, Ni X, Haffner M, et al (2009). miR-21: an androgen receptor-regulated microRNA that promotes hormonedependent and hormone-independent prostate cancer growth. Cancer Res, 69, 7165-9.
15. Ru P, Steele R, Newhall P, et al (2012). miRNA-29b suppresses prostate cancer metastasis by regulating epithelialmesenchymal transition signaling. Mol Cancer Ther, 11, 1166-73.
16. Shen L, Li J, Xu, L, et al (2012). miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. Exp Ther Med, 3, 475-80.
17. Siegel R, Naishadham, D, Jemal A (2012). Cancer statistics. CA Cancer J Clin, 62, 10-29.
18. Sun H, Li QW, Lv XY, et al (2010). MicroRNA-17 posttranscriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation. Mol Biol Rep, 37, 2951-8.
19. Vasudevan S, Tong Y, Steitz JA (2007). Switching from repression to activation: microRNAs can up-regulate translation. Science, 318, 1931-4.
20. Watahiki A, Wang Y, Morris J, et al (2011). MicroRNAs associated with metastatic prostate cancer. PLoS One, 6, e24950.
21. Yadav S, Pandey A, Shukla A, et al (2011). miR-497 and miR- 302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2. J Biol Chem, 286, 37347-57.
22. Zhang J, Yang Y, Yang T, et al (2010). microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer, 103, 1215-20.
23. Zheng D, Radziszewska A, Woo P (2012). MicroRNA 497 modulates interleukin 1 signalling via the MAPK/ERK pathway. FEBS Lett, 586, 4165-72.
24. Zhu W, Zhu D, Lu S, et al (2012). miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med Oncol, 29, 384-91.